BackGrey Matters Health Overview

Grey Matters Health EBIT

Track Grey Matters Health's EBIT ($-1.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$562.11K
↑ 3.62% YoY

As of May 31, 2026

Annual EBIT (TTM)

-$1.58M
↑ 6.63% YoY

Trailing 12 months ending May 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Grey Matters Health (AGNPF) FAQ

The latest EBIT for AGNPF is $-1.6M as of May 2026. That compares with $-1.7M in the prior-year period — up 6.6% year over year. That is below the Healthcare sector average of $1.9T. Investors often review this figure alongside Grey Matters Health's historical trend and sector peers before judging valuation or financial health.

Over the past year, AGNPF's EBIT moved from $-1.7M to $-1.6M — a 6.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Grey Matters Health's operating scale or balance-sheet position.

Against Healthcare companies, AGNPF currently prints $-1.6M for EBIT, while the sector average sits near $1.9T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Grey Matters Health's growth, margins, and balance sheet.

A EBIT figure of $-1.6M for AGNPF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $1.9T. Explore the charts below for those layers of context.

After noting AGNPF's EBIT ($-1.6M), review year-over-year change from $-1.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers